Research
Hormonal
GLP-1 agonists are approved for weight loss in addition to their original approval for type 2 diabetes.
Healthcare providers should consider GLP-1 agonists for patients needing weight loss support.
StrongSupportsmedium confidence
One of the beneficial effects of this medication class is weight loss, and recently the FDA has approved a select few for this indication of weight loss.
Why this rating
The claim is based on FDA approval, which is a strong form of evidence.
Source
GLP-1 Agonists for Weight Loss and Beyond
Connor Quinter et al. · Transformative Medicine · 2024
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →